Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
(RTTNews) - Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
Lockwood-Taylor joins Perrigo from Bayer AG, where he served a dual role as President of the approximately $15 billion revenue Bayer U.S. business and Regional President of Consumer Health North America.
Before Bayer, Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions.
In total, Lockwood-Taylor's career spans more than 25 years of experience in global consumer product leadership roles, including positions in operations management, sales, marketing, country management and general management across four continents.
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
Perrigo Guides FY24 Well Below Estimates - Update
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
U.S. Retail Sales Climb 0.5% In July, In Line With Estimates
U.S. Industrial Production Edges Slightly Lower In July
New York Manufacturing Index Unexpectedly Increases In August
